GuoLine Advisory’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Hold
310,700
1.85% 21
2026
Q1
$22.1M Hold
310,700
2.31% 16
2025
Q4
$25.5M Hold
310,700
2.34% 17
2025
Q3
$23.3M Hold
310,700
2.33% 21
2025
Q2
$23M Hold
310,700
2.44% 21
2025
Q1
$25.1M Sell
310,700
-76,400
-20% -$6.57M 2.65% 19
2024
Q4
$30.3M Hold
387,100
3.12% 16
2024
Q3
$36.3M Sell
387,100
-73,900
-16% -$6.2M 3.7% 12
2024
Q2
$35.9M Hold
461,000
3.83% 14
2024
Q1
$41.9M Sell
461,000
-145,964
-24% -$12.1M 5.11% 7
2023
Q4
$46.9M Hold
606,964
7.43% 6
2023
Q3
$41.3M Hold
606,964
8.15% 7
2023
Q2
$49.3M Buy
606,964
+67,000
+12% +$5.35M 9.72% 4
2023
Q1
$44.3M Buy
+539,964
New +$38.6M 12.44% 5

Other funds holding GEHC

GuoLine Advisory's GEHC Position: Q2 2026 in Review

GuoLine Advisory held its GE HealthCare (GEHC) position steady in Q2 2026 at 310,700 shares worth $19.9M. The position accounts for 1.85% of the portfolio, ranked #21.

GuoLine Advisory first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $49.3M in Q2 2023. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • GuoLine Advisory held 310,700 shares of GE HealthCare worth $19.9M as of Q2 2026.
  • GuoLine Advisory left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up 1.85% of GuoLine Advisory's portfolio in Q2 2026, its #21 holding.
  • GuoLine Advisory first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • GuoLine Advisory's GE HealthCare position peaked at $49.3M in Q2 2023.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on GuoLine Advisory's 13F filing for Q2 2026, filed 16 Jul 2026.